source
- Telix to acquire ITM Isotope Technologies in $1.65 billion radiopharma mergerITM Isotope Technologies Munich SE and Telix Pharmaceuticals announced a merger that will combine two leading radiopharmaceutical developers. The transaction is valued at a minimum of $1.65 billio…
- Jehovah's Witnesses ease ban, permitting blood-derived products while still forbidding whole-blood transfusionsThe religious group announced a revision to its long-standing medical policy, now allowing members to receive products derived from donated blood. The new guidance says individuals may accept plas…